目的 观察血管内皮生长抑制因子(VEGI)及其相关因子在糖尿病(DM)大鼠外周血、玻璃体液及视网膜组织中的表达,探讨VEGI在糖尿病视网膜病变(DR)发病机制中的作用.方法 70只6周龄雄性Wistar大鼠,随机分为空白对照组(10只),DM 1、3、6个月组(各20只).DM大鼠模型建立后,分别于1、3、6个月时取大鼠外周血、玻璃体液、全眼球.酶联免疫吸附测定法检测肿瘤坏死因子样配体1/血管内皮生长抑制因子251(TL1A/VEGI 251)、血管内皮生长因子(VEGF)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)在血清及玻璃体液浓度,石蜡切片免疫组织化学法检测各因子在视网膜组织中的表达,苏木素-伊红(HE)染色评价各组大鼠DR进程.比较空白对照组和DM实验组间大鼠血清、玻璃体液及视网膜组织中TL1A、VEGF、TNF-α、IL-1β的表达差异.结果 分析采用单因素方差分析、独立样本f检验和最小显著差法检验.结果 空白对照组、DM 1、3、6个月组大鼠血清TL1A浓度分别为(92.09±2.05)、(118.36±8.30)、(85.90±7.51)、(78.90±4.88) ng/L,组间血清TL1A浓度比较,差异有统计学意义(F=77.405,P<0.05).从空白对照组到DM 1、3、6个月组,大鼠血清TNF-α、IL-1β浓度均呈升高趋势,4组间血清TNF-α、IL-1β浓度比较,差异有统计学意义(F=3.508、15.416,P<0.05).VEGF浓度在DM 1个月时升高,DM 3个月时下降,DM 6个月时再次升高,但4组间VEGF浓度比较,差异无统计学意义(F=1.242,P>0.05).各组大鼠玻璃体液TL1A浓度分别为(91.50±8.18)、(67.03±6.74)、(47.44±4.92)、(46.01±4.62) ng/L,组间TL1A浓度比较,差异有统计学意义(F=114.777,P<0.05).从空白对照组到DM 1、3、6个月组,大鼠玻璃体液VEGF、TNF-α、IL-1β浓度均呈升高趋势,4组间VEGF、TNF-α、IL-1β比较,差异有统计学意义(F=8.816、4.392、3.635,P<0.05).免疫组织化学检测结果显示,DM 1、3个月组大鼠视网膜TL1A表达吸光度[A,旧称光密度(OD)]值均较空白对照组降低(t=6.851、6.066,P<0.05),但DM 6个月组与空白对照组的TL1A表达A值比较,差异无统计学意义(t=1.401,P>0.05);DM各组大鼠视网膜VEGF和TNF-α表达A值均较空白对照组显著升高(tVEGF=-4.709、-16.406、-9.228,P<0.05;t TNF.=-4.703、-6.583、-17.762,P<0.05);DM 1、6个月组大鼠视网膜IL-1β表达A值均较空白对照组显著升高(t=-4.108、-3.495,P<0.05),但DM 3个月组与空白对照组IL-1β表达A值比较,差异无统计学意义(t=-0.997,P>0.05).HE染色结果显示,空白对照组与DM 1个月组大鼠视网膜组织结构基本正常;DM 3个月组大鼠视网膜组织水肿,细胞排列紊乱;DM 6个月组大鼠视网膜组织明显水肿,神经节细胞核染色加深,内丛状层可见大量新生血管,内核层细胞排列紊乱、水肿,可见大量脂肪空泡,视网膜各层结构不清晰.结论 VEGI可能通过与VEGF、TNF-α、IL-1β等因子的相互作用参与DR的发生发展过程.
目的 觀察血管內皮生長抑製因子(VEGI)及其相關因子在糖尿病(DM)大鼠外週血、玻璃體液及視網膜組織中的錶達,探討VEGI在糖尿病視網膜病變(DR)髮病機製中的作用.方法 70隻6週齡雄性Wistar大鼠,隨機分為空白對照組(10隻),DM 1、3、6箇月組(各20隻).DM大鼠模型建立後,分彆于1、3、6箇月時取大鼠外週血、玻璃體液、全眼毬.酶聯免疫吸附測定法檢測腫瘤壞死因子樣配體1/血管內皮生長抑製因子251(TL1A/VEGI 251)、血管內皮生長因子(VEGF)、腫瘤壞死因子-α(TNF-α)、白細胞介素-1β(IL-1β)在血清及玻璃體液濃度,石蠟切片免疫組織化學法檢測各因子在視網膜組織中的錶達,囌木素-伊紅(HE)染色評價各組大鼠DR進程.比較空白對照組和DM實驗組間大鼠血清、玻璃體液及視網膜組織中TL1A、VEGF、TNF-α、IL-1β的錶達差異.結果 分析採用單因素方差分析、獨立樣本f檢驗和最小顯著差法檢驗.結果 空白對照組、DM 1、3、6箇月組大鼠血清TL1A濃度分彆為(92.09±2.05)、(118.36±8.30)、(85.90±7.51)、(78.90±4.88) ng/L,組間血清TL1A濃度比較,差異有統計學意義(F=77.405,P<0.05).從空白對照組到DM 1、3、6箇月組,大鼠血清TNF-α、IL-1β濃度均呈升高趨勢,4組間血清TNF-α、IL-1β濃度比較,差異有統計學意義(F=3.508、15.416,P<0.05).VEGF濃度在DM 1箇月時升高,DM 3箇月時下降,DM 6箇月時再次升高,但4組間VEGF濃度比較,差異無統計學意義(F=1.242,P>0.05).各組大鼠玻璃體液TL1A濃度分彆為(91.50±8.18)、(67.03±6.74)、(47.44±4.92)、(46.01±4.62) ng/L,組間TL1A濃度比較,差異有統計學意義(F=114.777,P<0.05).從空白對照組到DM 1、3、6箇月組,大鼠玻璃體液VEGF、TNF-α、IL-1β濃度均呈升高趨勢,4組間VEGF、TNF-α、IL-1β比較,差異有統計學意義(F=8.816、4.392、3.635,P<0.05).免疫組織化學檢測結果顯示,DM 1、3箇月組大鼠視網膜TL1A錶達吸光度[A,舊稱光密度(OD)]值均較空白對照組降低(t=6.851、6.066,P<0.05),但DM 6箇月組與空白對照組的TL1A錶達A值比較,差異無統計學意義(t=1.401,P>0.05);DM各組大鼠視網膜VEGF和TNF-α錶達A值均較空白對照組顯著升高(tVEGF=-4.709、-16.406、-9.228,P<0.05;t TNF.=-4.703、-6.583、-17.762,P<0.05);DM 1、6箇月組大鼠視網膜IL-1β錶達A值均較空白對照組顯著升高(t=-4.108、-3.495,P<0.05),但DM 3箇月組與空白對照組IL-1β錶達A值比較,差異無統計學意義(t=-0.997,P>0.05).HE染色結果顯示,空白對照組與DM 1箇月組大鼠視網膜組織結構基本正常;DM 3箇月組大鼠視網膜組織水腫,細胞排列紊亂;DM 6箇月組大鼠視網膜組織明顯水腫,神經節細胞覈染色加深,內叢狀層可見大量新生血管,內覈層細胞排列紊亂、水腫,可見大量脂肪空泡,視網膜各層結構不清晰.結論 VEGI可能通過與VEGF、TNF-α、IL-1β等因子的相互作用參與DR的髮生髮展過程.
목적 관찰혈관내피생장억제인자(VEGI)급기상관인자재당뇨병(DM)대서외주혈、파리체액급시망막조직중적표체,탐토VEGI재당뇨병시망막병변(DR)발병궤제중적작용.방법 70지6주령웅성Wistar대서,수궤분위공백대조조(10지),DM 1、3、6개월조(각20지).DM대서모형건립후,분별우1、3、6개월시취대서외주혈、파리체액、전안구.매련면역흡부측정법검측종류배사인자양배체1/혈관내피생장억제인자251(TL1A/VEGI 251)、혈관내피생장인자(VEGF)、종류배사인자-α(TNF-α)、백세포개소-1β(IL-1β)재혈청급파리체액농도,석사절편면역조직화학법검측각인자재시망막조직중적표체,소목소-이홍(HE)염색평개각조대서DR진정.비교공백대조조화DM실험조간대서혈청、파리체액급시망막조직중TL1A、VEGF、TNF-α、IL-1β적표체차이.결과 분석채용단인소방차분석、독립양본f검험화최소현저차법검험.결과 공백대조조、DM 1、3、6개월조대서혈청TL1A농도분별위(92.09±2.05)、(118.36±8.30)、(85.90±7.51)、(78.90±4.88) ng/L,조간혈청TL1A농도비교,차이유통계학의의(F=77.405,P<0.05).종공백대조조도DM 1、3、6개월조,대서혈청TNF-α、IL-1β농도균정승고추세,4조간혈청TNF-α、IL-1β농도비교,차이유통계학의의(F=3.508、15.416,P<0.05).VEGF농도재DM 1개월시승고,DM 3개월시하강,DM 6개월시재차승고,단4조간VEGF농도비교,차이무통계학의의(F=1.242,P>0.05).각조대서파리체액TL1A농도분별위(91.50±8.18)、(67.03±6.74)、(47.44±4.92)、(46.01±4.62) ng/L,조간TL1A농도비교,차이유통계학의의(F=114.777,P<0.05).종공백대조조도DM 1、3、6개월조,대서파리체액VEGF、TNF-α、IL-1β농도균정승고추세,4조간VEGF、TNF-α、IL-1β비교,차이유통계학의의(F=8.816、4.392、3.635,P<0.05).면역조직화학검측결과현시,DM 1、3개월조대서시망막TL1A표체흡광도[A,구칭광밀도(OD)]치균교공백대조조강저(t=6.851、6.066,P<0.05),단DM 6개월조여공백대조조적TL1A표체A치비교,차이무통계학의의(t=1.401,P>0.05);DM각조대서시망막VEGF화TNF-α표체A치균교공백대조조현저승고(tVEGF=-4.709、-16.406、-9.228,P<0.05;t TNF.=-4.703、-6.583、-17.762,P<0.05);DM 1、6개월조대서시망막IL-1β표체A치균교공백대조조현저승고(t=-4.108、-3.495,P<0.05),단DM 3개월조여공백대조조IL-1β표체A치비교,차이무통계학의의(t=-0.997,P>0.05).HE염색결과현시,공백대조조여DM 1개월조대서시망막조직결구기본정상;DM 3개월조대서시망막조직수종,세포배렬문란;DM 6개월조대서시망막조직명현수종,신경절세포핵염색가심,내총상층가견대량신생혈관,내핵층세포배렬문란、수종,가견대량지방공포,시망막각층결구불청석.결론 VEGI가능통과여VEGF、TNF-α、IL-1β등인자적상호작용삼여DR적발생발전과정.
Objective To observe the expression of vascular endothelial growth inhibitor VEGI.TL1A),vascular endothelial growth factor (VEGF),tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in diabetes rats' serum,vitreous and retina,and discuss the role of VEGI in the pathogenesis of diabetic retinopathy (DR).Methods A total of p70 adult male Wistar rats were randomly divided into 4 groups,the control group (10 rats),the diabetes mellitus (DM) 1 month group (20 rats),the DM 3 month group (20 rats) and the DM 6 month group (20 rats).Cytokines of serum and vitreous were determined by enzyme-linked immunosorbent assay (ELISA),and the concentrations of the cytokines in the retina were determined by immunohistochemistry on paraffin retinal sections.Hematoxylin-eosin (HE) staining of retina was used to estimate the pathological change of DR.The results were analyzed by one-way analysis of variances,independent samples t-test and LSD test.Results The serum TL1A levels of the control group,the DM 1 month group,the DM 3 month group and the DM 6 month group rats were (92.09 ±2.05),(118.364±8.30),(85.904±7.51) and (78.904±4.88) ng/L respectively,the level of TL1A in serum of the DM 1 month group,the DM 3 month group and the DM 6 month group were significantly lower than that of the control group (F=77.405,P<0.05).The concentration of serum TNF-α and IL-1β increased after DM model was established (F=3.508,15.416; P<0.05); the VEGF level in serum showed no difference between the groups (F=1.242,P>0.05).The vitreous TL1A levels of the control group,the DM 1 month group,the DM 3 month group and the DM 6 month group were (91.50±8.18),(67.03±6.74),(47.44±4.92) and (46.01±4.62) ng/L respectively,every DM groups showed significant difference with the control group (F=114.777,P<0.05); VEGF level in vitreous increased from 1 month after DM model was established (F=8.816,P<0.05) ; TNF-α and IL-1β level in vitreous also showed an upward tendency (F=4.392,3.635; P<0.05).Paraffin section immunohistochemistry showed that the absorbance (also called optical density) of TLIA of the DM 1 month group and the DM 3 month group were significantly lower than that of the control group (t=6.851,6.066; P<0.05),but the DM 6 month group showed no difference with the control group (t=1.401,P>0.05) ; the level of VEGF and TNF-α in DM groups were higher than that of the control group (tVEGF =-4.709,-16.406,-9.228; tTNF-α =-4.703,-6.583,-17.762; P<0.05) ; the level of IL-1β were significantly higher in the DM 1 month group and the DM 6 month group (t=-4.108,-3.495; P>0.05); but the DM 3 month showed no difference with the control group (t=-0.997,P>0.05).HE staining of retina showed that the retina of the control group and the DM 1 month group had normal retinal structures,the DM 3 month group had retinal edema and disorganization,the DM 6 month group had severe retinal edema,deep stain of ganglion cells,and more neovascularization in inner plexiform layer.Conclusion VEGI is involved in the pathogenesis of DR,and it might interacts with VEGF,TNF-α and IL-1β to affect the development of DR.